IntegraGen is a leader in genome analysis and the development and commercialization of molecular diagnostic tests for oncology.
Genomic Services
miRpredX 31-3p
Investors
Latest news // Archive
-
Press releases
IntegraGen announces 2019 revenue of €8.3 million, up +20%, and cash position of €2.8 million as of December 31
-
Press releases
IntegraGen announces 2019 first half results: Continued improvement in profitability
-
Press releases
IntegraGen reports sales of € 4.2 million in the first half of 2019, up 15%